| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/11/2008 | CN101194905A Dropping pills containing domperidone and method for preparing the same |
| 06/11/2008 | CN101194904A Dropping pills containing perhexiline maleic acid and method for preparing the same |
| 06/11/2008 | CN101194903A Dropping pills containing Isocarboxazid and method for preparing the same |
| 06/11/2008 | CN101194902A Dropping pills containing ubenimex and method for preparing the same |
| 06/11/2008 | CN101194896A Dropping pills containing berberine or berberine salt and method for preparing the same |
| 06/11/2008 | CN101194895A Dropping pills containing ursolic acid and method for preparing the same |
| 06/11/2008 | CN101194894A Dropping pills containing tegaserod maleate and method for preparing the same |
| 06/11/2008 | CN101194893A Dropping pills containing lovastatin and method for preparing the same |
| 06/11/2008 | CN101194892A Dropping pills containing benproperine phosphate and method for preparing the same |
| 06/11/2008 | CN101194891A Dropping pills containing bulleyaconitine and method for preparing the same |
| 06/11/2008 | CN100393782C Carboxymethyl chitosan nanoparticles as medicine carrier and method for preparing same |
| 06/11/2008 | CN100393356C Modified cytokines for use in cancer therapy |
| 06/11/2008 | CN100393319C Astragaloside cyclodextrin clathrate, its preparation and preparing mehtod |
| 06/11/2008 | CN100393313C Bilobalide B powder injection and its preparing method |
| 06/11/2008 | CN100393304C Fine granules containing acid-labile medicine and preparation thereof |
| 06/11/2008 | CN100393301C Molecular gel transdermal medicine preparation and its preparing method |
| 06/10/2008 | US7385068 Stearate composition and method |
| 06/10/2008 | US7385052 Preparing preefrentially linked chemical intermediates; obtain hyaluronic acid, incubate with glutaraldehyde, recover reaction product |
| 06/10/2008 | US7385026 Modified ghrelin polypeptides |
| 06/10/2008 | US7384984 Reactive hydrophilic oligomers |
| 06/10/2008 | US7384982 e.g., disodium N-(5-chlorosalicyloyl)-8-amN-(10-[2-hydroxybenzoyl]amino)decanoate and disodium N-(10-[2-hydroxybenzoyl]amino)decanoate |
| 06/10/2008 | US7384977 polymer conjugated drug with polylactams; antitumor, anticancer agents for prostate cancer, breast cancer, ovarian cancer, colon cancer, leukemia, and lung cancer; rheumatic diseases; autoimmune diseases |
| 06/10/2008 | US7384976 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 06/10/2008 | US7384919 Nontoxic; spray drying or freeze drying |
| 06/10/2008 | US7384650 A skin permeation enhancer for enhancing absorption of a steroid hormone through the skin, containing an organic solvent, a fatty (C8-C20) alcohol ester of a hydroxy acid, a lower alkyl ester of hydroxy acid and a (C6-C18) fatty acid |
| 06/10/2008 | US7384649 Particulate compositions for pulmonary delivery |
| 06/10/2008 | US7384646 Antiseptic disinfectant, and cosmetics and toiletries, medicine or food containing the same |
| 06/10/2008 | US7384631 Contacting myeloid cells in a sample with a ligand directed against p75/AIRM1(75 kd adhesion inhibitory receptor molecule1) receptor, and determining binding of the ligand |
| 06/10/2008 | US7384626 Quaternary ammonium functionalized dendritic polymers and N-Halamine functionalized dendritic polymers for capture and neutralization of biological and chemical warfare agents |
| 06/10/2008 | US7384478 Apparatus and process for preparing crystalline particles |
| 06/10/2008 | US7383970 Valve with a two-component seal |
| 06/10/2008 | US7383788 Enhanced feeding and growth rates of aquatic animals fed an astaxanthin product derived from marigold extract |
| 06/10/2008 | CA2465675C Improved particulate compositions for pulmonary delivery |
| 06/10/2008 | CA2376121C Stable xylometazoline and oxymetazoline solution |
| 06/10/2008 | CA2365826C Over-coated chewing gum formulations |
| 06/10/2008 | CA2361981C Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 06/10/2008 | CA2358040C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 06/10/2008 | CA2345121C Pharmaceutical composition for the treatment of acute disorders |
| 06/10/2008 | CA2341814C Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues |
| 06/10/2008 | CA2329768C Pharmaceutical composition comprising factor viii and neutral liposomes |
| 06/10/2008 | CA2329234C Controlled release peroral compositions of levosimendan |
| 06/10/2008 | CA2319010C Pharmaceutical compositions |
| 06/10/2008 | CA2311530C Nasal solutions |
| 06/10/2008 | CA2284107C Activation of peptides |
| 06/10/2008 | CA2250010C Denaturants for sympathomimetic amine salts |
| 06/10/2008 | CA2230730C Microemulsions for use as vehicles for administration of active compounds |
| 06/10/2008 | CA2214100C Sustained release formulation containing three different types of polymers |
| 06/10/2008 | CA2200595C Use of starch for transdermal applications |
| 06/10/2008 | CA2153756C Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, dna sequences encoding it and their use |
| 06/08/2008 | CA2572004A1 Tablets comprising entacapone and crospovidone |
| 06/05/2008 | WO2008066902A2 Method for preparing a polymer conjugate |
| 06/05/2008 | WO2008066507A2 Nanotube devices for targeted delivery of therapeutic molecules |
| 06/05/2008 | WO2008066185A1 Method for prevention of discoloration with time of donepezil-containing skin adhesive preparation |
| 06/05/2008 | WO2008066184A1 Method for prevention of coloration in donepezil-containing skin adhesive preparation, and method for reducing the production of donepezil analogue in donepezil-containing skin adhesive preparation |
| 06/05/2008 | WO2008066183A1 Skin adhesive preparation comprising stabilized donepezil |
| 06/05/2008 | WO2008066180A1 Skin adhesive preparation comprising stabilized donepezil |
| 06/05/2008 | WO2008066179A1 Percutaneous absorption preparation |
| 06/05/2008 | WO2008066115A1 Adhesive skin patch and method for evaluation of adhesive skin patch |
| 06/05/2008 | WO2008066102A1 Sustained release preparation |
| 06/05/2008 | WO2008065451A2 Compositions comprising macromolecular assemblies of lipid and surfactant |
| 06/05/2008 | WO2008065306A1 Benzoyl peroxyde comprising compositions, at least one naphtoic acid derivative and at least one compound of polyurethane polymer-type or derivatives thereof, and their use |
| 06/05/2008 | WO2008065142A1 Stabilized solution of rocuronium comprising a sulfoalkyl-ether-beta-cyclodextrin derivative |
| 06/05/2008 | WO2008064910A2 Metastasis-specific peptides and their diagnostic and therapeutic applications |
| 06/05/2008 | WO2008064815A2 Preparation for transdermally administering galanthamine |
| 06/05/2008 | WO2008048801A3 Phenylalkylamino carbamate compositions |
| 06/05/2008 | WO2008013454B1 Immunogenic compounds and protein mimics |
| 06/05/2008 | WO2008001200A3 Transdermal composition having enhanced color stability |
| 06/05/2008 | WO2007113856A3 Directly compressible composite for orally disintegrating tablets |
| 06/05/2008 | WO2007113224A3 Conjugation process for pnag and a carrier protein |
| 06/05/2008 | WO2007018431A3 Triazole-containing releasable linkers and conjugates comprising the same |
| 06/05/2008 | US20080132963 Method and apparatus for treating tumors using low strength electric fields |
| 06/05/2008 | US20080132585 Separate type medical material |
| 06/05/2008 | US20080132584 nanoscale dimensions enabling the non-destructive penetration of lipid membranes; functionalized to perform a bio-chemical process using bio-compatible, porous coating in which enzymes are structurally constrained |
| 06/05/2008 | US20080132582 Propofol formulation containing reduced oil and surfactants |
| 06/05/2008 | US20080132578 venlafaxine metabolites used for treating and preventing psychological disorders, Parkinson's disease, epilepsy, obesity, incontinence or Alzheimer's disease; side effect reduction |
| 06/05/2008 | US20080132564 Micellar drug delivery vehicles and precursors thereto and uses thereof |
| 06/05/2008 | US20080132539 e.g. 2-amino-5-[(naphthalen-1-ylmethyl)-aminocarbonyl]-pentanoic acid hydroxyamide; advanced glycosylation endproducts inhibitor; diabetic neurosis, diabetic retinopathy, atherosclerosis, cataract, Alzheimer's disease, rheumatic arthritis, osteoarthritis, chronic renal failure; food and cosmetics |
| 06/05/2008 | US20080132533 Solid Dispersion Comprising Tacrolimus and Entericcoated Macromolecule |
| 06/05/2008 | US20080132514 bi-functional organic molecules which combine serotonin transporter reuptake inhibition with serotonin (5-HT, such as 5-HT2A) receptor antagonism in one molecular entity |
| 06/05/2008 | US20080132512 Combination of Brimonidine and Timolol for Topical Ophthalmic Use |
| 06/05/2008 | US20080132493 Aqueous cyclodextrin-free solution; analgesics, antiinflammatories, antipyretics |
| 06/05/2008 | US20080132456 Pharmaceutical Formulation Comprising Low Crystallinity Cellulose |
| 06/05/2008 | US20080132444 Ocular Agent Delivery Systems |
| 06/05/2008 | US20080131871 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators |
| 06/05/2008 | US20080131565 Edible composition; partially defatted cocoa solids prepared by heating slaty and/or purple cocoa beans, winnowing the cocoa nibs from the cocoa shells; pressing the cocoa nibs to produce cocoa butter, recovering the cocoa butter and solids; adding the recovered, defatted cocoa solids |
| 06/05/2008 | US20080131524 Compositions for treatment of viral-induced skin lesions and methods of using same |
| 06/05/2008 | US20080131520 Silk fibroin from domesticated silkworm; sustained release; waste treatment |
| 06/05/2008 | US20080131516 Granule formation |
| 06/05/2008 | US20080131515 Small particle size of emulsified particles and excellent emulsion stability (transparency) even when sodium ascorbate or catechin is added; phospholipid, an oil-based component and a surfactant in specified amount |
| 06/05/2008 | US20080131512 Biodegradable hydrogels |
| 06/05/2008 | US20080131510 Composition and method for providing localized delivery of a therapeutic agent |
| 06/05/2008 | US20080131509 Self-reinforcing composite biomatrix; use in tissue repair of myocardial infarct for example; two-component gelation system, and a silk protein such as silk-elastin, silk-collagen, silk-laminin, optionally conjugated to a biopolymer |
| 06/05/2008 | US20080131506 and as additive fatty acids or salts, fatty esters, lipid materials, polysaccharides, polyvinylpyrrolidones, acrylic compounds, glycerides, animal proteins or mixtures thereof; sustained release of drug or nutrient; calcium carbonate replaces organic compound normally found in prolonged release dosages |
| 06/05/2008 | US20080131500 methods of inactivating a protein, such as cleaving a disulfide bond of a protein, that involve contacting the protein with a reducing agent, a denaturant, and a hydroxide ion, wherein the pH of the composition is about 10.0 to about 14.0. Also disclosed are methods of treating or preventing a disease |
| 06/05/2008 | US20080131499 Method and composition for solubilising a biologically active compound with low water solubilty |
| 06/05/2008 | US20080131494 Dermal Penetration enhancers and drug delivery systems involving same |
| 06/05/2008 | US20080131493 multilayered composite sheet for delivering one or more therapeutic agents to the skin is disclosed. The composite sheet comprises a flexible porous polymer with open cells of a sufficient size for holding a therapeutic agent, an encapsulating agent for encapsulating the flexible porous polymer |
| 06/05/2008 | US20080131489 composite structure suitable for making transdermal delivery devices includes in sequence: (a) a liner film layer; (b) a containment layer having from zero to 15 wt. % content of vinyl acetate repeating units, the layer including either a thermal bonding copolyester resin or a combination of an ethylene |
| 06/05/2008 | US20080131488 Medical Tape Preparation |
| 06/05/2008 | US20080131487 medical or dietary treatments comprising administration of a zymogen such as chymosin or other rennins. Embodiments of the invention are directed to treating infant colic, heartburn, gastro-esophageal reflux (GER), gastro-esophageal reflux disease (GERD), irritable bowel syndrome, and recurrent abdominal |